These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
849 related items for PubMed ID: 8757192
1. Case-control study of endogenous steroid hormones and endometrial cancer. Potischman N, Hoover RN, Brinton LA, Siiteri P, Dorgan JF, Swanson CA, Berman ML, Mortel R, Twiggs LB, Barrett RJ, Wilbanks GD, Persky V, Lurain JR. J Natl Cancer Inst; 1996 Aug 21; 88(16):1127-35. PubMed ID: 8757192 [Abstract] [Full Text] [Related]
4. Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Lukanova A, Lundin E, Micheli A, Arslan A, Ferrari P, Rinaldi S, Krogh V, Lenner P, Shore RE, Biessy C, Muti P, Riboli E, Koenig KL, Levitz M, Stattin P, Berrino F, Hallmans G, Kaaks R, Toniolo P, Zeleniuch-Jacquotte A. Int J Cancer; 2004 Jan 20; 108(3):425-32. PubMed ID: 14648710 [Abstract] [Full Text] [Related]
5. Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-Analysis. Mori N, Keski-Rahkonen P, Gicquiau A, Rinaldi S, Dimou N, Harlid S, Harbs J, Van Guelpen B, Aune D, Cross AJ, Tsilidis KK, Severi G, Kvaskoff M, Fournier A, Kaaks R, Fortner RT, Schulze MB, Jakszyn P, Sánchez MJ, Colorado-Yohar SM, Ardanaz E, Travis R, Watts EL, Masala G, Krogh V, Tumino R, Sacerdote C, Panico S, Bueno-de-Mesquita B, Gram IT, Waaseth M, Gunter MJ, Murphy N. JNCI Cancer Spectr; 2021 Dec 20; 5(6):. PubMed ID: 34805742 [Abstract] [Full Text] [Related]
6. A prospective study of endogenous estrogens and breast cancer in postmenopausal women. Toniolo PG, Levitz M, Zeleniuch-Jacquotte A, Banerjee S, Koenig KL, Shore RE, Strax P, Pasternack BS. J Natl Cancer Inst; 1995 Feb 01; 87(3):190-7. PubMed ID: 7707406 [Abstract] [Full Text] [Related]
8. A Prospective Evaluation of Endogenous Sex Hormone Levels and Colorectal Cancer Risk in Postmenopausal Women. Murphy N, Strickler HD, Stanczyk FZ, Xue X, Wassertheil-Smoller S, Rohan TE, Ho GY, Anderson GL, Potter JD, Gunter MJ. J Natl Cancer Inst; 2015 Oct 01; 107(10):. PubMed ID: 26232761 [Abstract] [Full Text] [Related]
9. Prospective study of sex hormone levels and risk of prostate cancer. Gann PH, Hennekens CH, Ma J, Longcope C, Stampfer MJ. J Natl Cancer Inst; 1996 Aug 21; 88(16):1118-26. PubMed ID: 8757191 [Abstract] [Full Text] [Related]
10. Ovarian volumes among women with endometrial carcinoma: associations with risk factors and serum hormones. Sherman ME, Madigan MP, Lacey JV, Garcia-Closas M, Potischman N, Carreon JD, Hartge P, Brinton LA. Gynecol Oncol; 2007 Dec 21; 107(3):431-5. PubMed ID: 17720234 [Abstract] [Full Text] [Related]
11. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, Secreto G, Amiano P, Bingham S, Boeing H, Bueno de Mesquita HB, Chang-Claude J, Clavel-Chapelon F, Fournier A, van Gils CH, Gonzalez CA, Gurrea AB, Critselis E, Khaw KT, Krogh V, Lahmann PH, Nagel G, Olsen A, Onland-Moret NC, Overvad K, Palli D, Panico S, Peeters P, Quirós JR, Roddam A, Thiebaut A, Tjønneland A, Chirlaque MD, Trichopoulou A, Trichopoulos D, Tumino R, Vineis P, Norat T, Ferrari P, Slimani N, Riboli E. J Natl Cancer Inst; 2005 May 18; 97(10):755-65. PubMed ID: 15900045 [Abstract] [Full Text] [Related]
12. Polymorphisms associated with circulating sex hormone levels in postmenopausal women. Dunning AM, Dowsett M, Healey CS, Tee L, Luben RN, Folkerd E, Novik KL, Kelemen L, Ogata S, Pharoah PD, Easton DF, Day NE, Ponder BA. J Natl Cancer Inst; 2004 Jun 16; 96(12):936-45. PubMed ID: 15199113 [Abstract] [Full Text] [Related]
13. Plasma sex steroid hormones and breast cancer risk in Chinese women. Yu H, Shu XO, Shi R, Dai Q, Jin F, Gao YT, Li BD, Zheng W. Int J Cancer; 2003 May 20; 105(1):92-7. PubMed ID: 12672036 [Abstract] [Full Text] [Related]
16. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, Stanczyk FZ, Stephenson HE, Falk RT, Miller R, Schatzkin A, Allen DS, Fentiman IS, Key TJ, Wang DY, Dowsett M, Thomas HV, Hankinson SE, Toniolo P, Akhmedkhanov A, Koenig K, Shore RE, Zeleniuch-Jacquotte A, Berrino F, Muti P, Micheli A, Krogh V, Sieri S, Pala V, Venturelli E, Secreto G, Barrett-Connor E, Laughlin GA, Kabuto M, Akiba S, Stevens RG, Neriishi K, Land CE, Cauley JA, Kuller LH, Cummings SR, Helzlsouer KJ, Alberg AJ, Bush TL, Comstock GW, Gordon GB, Miller SR, Longcope C, Endogenous Hormones Breast Cancer Collaborative Group. J Natl Cancer Inst; 2003 Aug 20; 95(16):1218-26. PubMed ID: 12928347 [Abstract] [Full Text] [Related]
19. Postmenopausal breast cancer risk in relation to sex steroid hormones, prolactin and SHBG (Sweden). Manjer J, Johansson R, Berglund G, Janzon L, Kaaks R, Agren A, Lenner P. Cancer Causes Control; 2003 Sep 20; 14(7):599-607. PubMed ID: 14575357 [Abstract] [Full Text] [Related]
20. Serum sex hormone levels after menopause and subsequent breast cancer. Berrino F, Muti P, Micheli A, Bolelli G, Krogh V, Sciajno R, Pisani P, Panico S, Secreto G. J Natl Cancer Inst; 1996 Mar 06; 88(5):291-6. PubMed ID: 8614008 [Abstract] [Full Text] [Related] Page: [Next] [New Search]